ZA937405B - 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions - Google Patents

3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Info

Publication number
ZA937405B
ZA937405B ZA937405A ZA937405A ZA937405B ZA 937405 B ZA937405 B ZA 937405B ZA 937405 A ZA937405 A ZA 937405A ZA 937405 A ZA937405 A ZA 937405A ZA 937405 B ZA937405 B ZA 937405B
Authority
ZA
South Africa
Prior art keywords
oxindole
substituted
pharmaceutical compositions
carboxamide
carboxamide pharmaceutical
Prior art date
Application number
ZA937405A
Other languages
English (en)
Inventor
Imran Ahmed
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA937405B publication Critical patent/ZA937405B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • A61K31/405Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4858Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
ZA937405A 1992-10-07 1993-10-06 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions ZA937405B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US95793092A 1992-10-07 1992-10-07

Publications (1)

Publication Number Publication Date
ZA937405B true ZA937405B (en) 1995-04-06

Family

ID=25500362

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA937405A ZA937405B (en) 1992-10-07 1993-10-06 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions

Country Status (21)

Country Link
EP (1) EP0662831A1 (ko)
JP (1) JP2721042B2 (ko)
KR (1) KR950703338A (ko)
CN (1) CN1089138A (ko)
AU (1) AU676200B2 (ko)
BR (1) BR9307182A (ko)
CA (1) CA2146448A1 (ko)
CZ (1) CZ282702B6 (ko)
EG (1) EG20289A (ko)
FI (1) FI934387A (ko)
HU (1) HUT68533A (ko)
IL (1) IL107122A (ko)
MX (1) MX9306222A (ko)
MY (1) MY109680A (ko)
NO (1) NO951350L (ko)
NZ (1) NZ256164A (ko)
PL (1) PL174170B1 (ko)
RU (1) RU2119353C1 (ko)
TW (1) TW438798B (ko)
WO (1) WO1994007488A1 (ko)
ZA (1) ZA937405B (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2076106B1 (es) * 1993-08-26 1996-06-16 Pfizer Composiciones farmaceuticas a base de 2-oxindol-1-carboxamidas 3-sustituidas
WO1995031979A1 (en) * 1994-05-19 1995-11-30 R.P. Scherer International Corporation Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
UA42739C2 (uk) * 1995-04-24 2001-11-15 Пфайзер Інк. Спосіб інгібування фоторозкладу фармацевтично активних сполук, таблетка та капсула, що їх містять
WO1998029136A1 (en) * 1996-12-27 1998-07-09 Takeda Chemical Industries, Ltd. Stabilized tricyclic compound
JP5869764B2 (ja) * 2011-01-07 2016-02-24 中日本カプセル 株式会社 カプセル充填用組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
US5008283A (en) * 1990-03-19 1991-04-16 Pfizer Inc. Use of tenidap to inhibit activation of collagenase and to inhibit the activity of myeloperoxidase
DE69216642T2 (de) * 1992-01-13 1997-05-07 Pfizer Verfahren zur herstellung von tabletten mit hoher festigkeit

Also Published As

Publication number Publication date
JPH07507809A (ja) 1995-08-31
NO951350L (no) 1995-06-06
HUT68533A (en) 1995-04-27
MY109680A (en) 1997-04-30
FI934387A0 (fi) 1993-10-06
HU9302821D0 (en) 1993-12-28
IL107122A0 (en) 1993-12-28
JP2721042B2 (ja) 1998-03-04
EP0662831A1 (en) 1995-07-19
CZ282702B6 (cs) 1997-09-17
PL174170B1 (pl) 1998-06-30
AU676200B2 (en) 1997-03-06
BR9307182A (pt) 1999-03-30
NO951350D0 (no) 1995-04-06
IL107122A (en) 1998-08-16
MX9306222A (es) 1994-04-29
EG20289A (en) 1998-07-30
CA2146448A1 (en) 1994-04-14
RU2119353C1 (ru) 1998-09-27
CZ87895A3 (en) 1995-10-18
TW438798B (en) 2001-06-07
WO1994007488A1 (en) 1994-04-14
FI934387A (fi) 1994-04-08
CN1089138A (zh) 1994-07-13
NZ256164A (en) 1997-03-24
KR950703338A (ko) 1995-09-20
PL308307A1 (en) 1995-07-24
AU4839293A (en) 1994-04-26

Similar Documents

Publication Publication Date Title
GB9224855D0 (en) Pharmaceutical compositions
GB9209078D0 (en) Pharmaceutical compositions
GB9319500D0 (en) Pharmaceutical composition
HUT66864A (en) Pharmaceutical compositions
GB9317610D0 (en) Pharmaceutical compositions
GB2272375B (en) Pharmaceutical composition
GB9209874D0 (en) Pharmaceutical compositions
IL107122A0 (en) 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions
ZA937592B (en) Pharmaceutical composition
ZA935078B (en) Pharmaceutical composition
ZA94155B (en) Pharmaceutical composition
GB9226377D0 (en) Pharmaceutical compositions
GB9211276D0 (en) Pharmaceutical compositions
ZA924061B (en) Pharmaceutical composition
ZA935931B (en) Pharmaceutical composition
ZA931984B (en) Pharmaceutical composition
GB9222941D0 (en) Pharmaceutical compositions
ZA935161B (en) Pharmaceutical compositions
GB9221447D0 (en) Pharmaceutical compositions
ZA925331B (en) Pharmaceutical compositions
IL102579A0 (en) Pharmaceutical compositions
GB9221800D0 (en) Pharmaceutical compositions
GB9210226D0 (en) Pharmaceutical compositions
GB9222942D0 (en) Pharmaceutical compositions
GB9211400D0 (en) Pharmaceutical compositions